EXCESSIVE CHEMOTHERAPY-RELATED MYELOTOXICITY IN CHILDREN WITH DOWN SYNDROME AND ACUTE LYMPHOBLASTIC LEUKAEMIA

The Lancet

Volumn 328, Issue 8512, 1986, Pages 914-

  Blatt, Julie ^a   Albo, Vincent ^a   Prin, William ^a   Orlando, Salvatore ^a   Wollman, Michael ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONGENITAL DISORDER; DOWN SYNDROME; DRUG DOSE; DRUG THERAPY; HEREDITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; THERAPY;

ADOLESCENT; AGRANULOCYTOSIS; ANTINEOPLASTIC AGENTS; BONE MARROW; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; HUMANS; LEUKEMIA, LYMPHOCYTIC; METHOTREXATE; NEUTROPENIA;

EID: 0023006905     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(86)90429-0     Document Type: Letter

References (8)

1. Neoplasia and Down's syndrome
2. Down's syndrome and acute leukemia in children: a 10 year retrospective survey from Children's Cancer Study Group
3. Drug dosage and remission duration in childhood lymphocytic leukemia
4. Development and preliminary findings of Children's Cancer Study Group protocols (161, 162, 163) for low, average and high risk acute lymphoblastic leukemia in children
5. Comparison of intermediate dose methotrexate with cranial irradiation for the post induction treatment of acute lymphocytic leukemia in children
6. Leucocyte function in Down's syndrome and acute leukaemia
7. Leucocyte ultrastructure and folate metabolism in Down syndrome